WATERTOWN, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...
Analyst Evan Seigerman from BMO Capital maintained a Buy rating on Disc Medicine (IRON – Research Report) and keeping the price target at $112.00. Evan Seigerman has given his Buy rating due to a ...
If a new hard drive isn’t showing up in Disk Management, it often means the system isn’t recognizing the drive correctly, typically due to the drive being uninitialized, unformatted, or lacking an ...